PeptideDistro.com supplies research-grade peptides into wholesale programs. The quality assurance process below outlines supplier qualification, identity confirmation, HPLC purity review, mass spectrometry confirmation, COA / batch documentation, storage and handling, and the documentation request process used for qualified accounts.
Catalog peptides are sourced through qualified manufacturing partners with documented synthesis, purification, and analytical capability. Each supplier is reviewed against identity, purity, and documentation expectations before any peptide enters the catalog. Lot-level traceability is required for every supplied peptide.
High-performance liquid chromatography (HPLC) is used to confirm retention behavior and to measure purity against the lot release threshold. Chromatograms are reviewed for expected peak shape and impurity profile.
Mass spectrometry (MS) data is reviewed to confirm the observed monoisotopic / average mass against the expected molecular weight. The identity result is recorded against the lot record.
Each catalog entry is described against a documented sequence and any modifications (acetylation, amidation, PEGylation, fatty-acid conjugation, etc.). Sequence text and identifiers are maintained on the per-peptide page.
Each lot ships with a certificate of analysis (COA) summarizing identity, purity, and lot information. COAs are produced per lot and held against the buyer’s account record.
Wholesale and custom-blend lots can ship with a documentation packet covering identity, HPLC chromatogram, MS spectrum, lot/exp, fill counts, and label artwork as applicable.
Lot numbers and stated stability windows accompany each shipment. The lot record is preserved against the buyer’s account for documentation continuity.
Documentation is framed for research workflows. PeptideDistro.com does not produce clinical, dosage, administration, or therapeutic-use packets.
Each inbound lot is reviewed against accompanying COA and analytical data before it is staged for fulfillment. Discrepancies trigger an internal review before release.
Lyophilized peptides are stored under conditions appropriate to the catalog entry. Cold storage and light protection are used where indicated by stability data.
Each shipment includes general storage and handling guidance for research-workflow context. Reconstitution, sample preparation, and downstream handling remain the buyer’s responsibility under their own institutional protocols.
HPLC retention and MS mass observation are reviewed against the catalog entry.
HPLC purity is reviewed against the lot release threshold for the catalog entry.
COA, chromatogram, and MS spectrum are compiled into the lot record.
Lot is released for fulfillment to qualified accounts. Documentation is routed against the buyer record.
Approved buyers can request additional batch documentation through the quote request desk with intent=batch-docs or via the wholesale account contact.
Cross-reference: Products & Services · Research peptide directory · Wholesale programs · Custom blends · Compliance overview · Contact · About.
The QA process described above supports research-grade catalog supply. PeptideDistro.com does not manufacture, label, or release products for human or veterinary consumption, and does not provide medical, dosage, treatment, or clinical guidance.